VCA Specialty Update Symposium

VCA: Where are the limits, what is the future

09:00 – 12:50     VCA Specialty Update Symposium

CHAIRS:   Lionel Badet, Lyon, France
                 Emmanuel Morelon, Paris, France           

09:00     Limitations and results of face transplantation
             Sylvie Testelin, Amiens, France

09:30     Limitations and results of upper limb transplantation
             Stefan Schneeberger, Innsbruck, Austria

10:00     Laryngeal and Tracheal transplantation
             Pierre Delaere, Leuven, Belgium


10:40 – 11:10    Coffee Break


SESSION 2: Joint Session Basic Science & Vascularized Composite Allotransplantation

CHAIRS:  Pietro Cippà, Zurich, Switzerland
        Henri Leuvenink, Groningen, The Netherlands

11:10     Chronic rejection in VCA: from myth to reality
             Olivier Thaunat, Lyon, France

11:40    Cell-based therapy options in VCA
             Jan Plock, Zurich, Switzerland

12:10     What have we learned from animal models in VCA?  
             Gerald Brandacher, Baltimore, United States  




VCA in pills:
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This committee brings together 10 representatives of major European teams at the forefront in this field.

Our goal is to raise the scientific and clinical development of Vascularized Composite Allotransplantation (VCA) in Europe and to serve as a platform for scientists and clinicians for information and exchange.


  • Understand the risks and limits of face and upper limb transplantation
  • Discuss and implement new data to characterize chronic rejection
  • Discuss the contribution of animal models in VCA
  • Discuss alternatives strategies  for patients’ management

Target audience:
Surgeons, physicians, researchers, transplant coordinators


ESOT Office
Riviera dei Mugnai, 8/24
35137 Padova
T: +39 049 859 7652
F: +39 049 210 6306